↓ Skip to main content

Cochrane Database of Systematic Reviews

Sulfasalazine for ankylosing spondylitis

Overview of attention for article published in Cochrane database of systematic reviews, November 2014
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (81st percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
6 tweeters
facebook
2 Facebook pages
wikipedia
1 Wikipedia page

Citations

dimensions_citation
89 Dimensions

Readers on

mendeley
202 Mendeley
Title
Sulfasalazine for ankylosing spondylitis
Published in
Cochrane database of systematic reviews, November 2014
DOI 10.1002/14651858.cd004800.pub3
Pubmed ID
Authors

Junmin Chen, Shaopeng Lin, Chao Liu

Abstract

Ankylosing spondylitis (AS) is a chronic inflammatory disease of unknown cause and affects mainly the spine, but can also affect other joints. Disease progression may result in loss of mobility and function. Sulfasalazine is a disease-modifying antirheumatic drug used in the treatment of AS. However, its efficacy remains unclear. This is an update of a Cochrane review first published in 2005.

Twitter Demographics

The data shown below were collected from the profiles of 6 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 202 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Colombia 1 <1%
Switzerland 1 <1%
Unknown 200 99%

Demographic breakdown

Readers by professional status Count As %
Student > Master 30 15%
Student > Ph. D. Student 23 11%
Researcher 20 10%
Student > Doctoral Student 16 8%
Student > Bachelor 14 7%
Other 45 22%
Unknown 54 27%
Readers by discipline Count As %
Medicine and Dentistry 78 39%
Nursing and Health Professions 14 7%
Psychology 9 4%
Agricultural and Biological Sciences 6 3%
Pharmacology, Toxicology and Pharmaceutical Science 6 3%
Other 27 13%
Unknown 62 31%

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 November 2018.
All research outputs
#4,510,306
of 22,776,824 outputs
Outputs from Cochrane database of systematic reviews
#6,853
of 12,314 outputs
Outputs of similar age
#65,836
of 361,891 outputs
Outputs of similar age from Cochrane database of systematic reviews
#160
of 276 outputs
Altmetric has tracked 22,776,824 research outputs across all sources so far. Compared to these this one has done well and is in the 80th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,314 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 30.4. This one is in the 43rd percentile – i.e., 43% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 361,891 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 81% of its contemporaries.
We're also able to compare this research output to 276 others from the same source and published within six weeks on either side of this one. This one is in the 41st percentile – i.e., 41% of its contemporaries scored the same or lower than it.